The Pathology EDI committee has been hard at work developing the JEDI Plan (Justice, Equity, Diversity, and Inclusion) and is excited to begin the execution phase to accomplish our FY23 goals.
The JEDI Plan outlines overarching department goals over a 3-5 year period for the following domains: People, Climate, Structural Elements, Professional Development/Education, Community Engagement, and Patient Care. The goals will be evaluated each year to discern progress made and identify improvement areas. They will establish subcommittees for each domain, so if you are interested in joining, please be on the lookout for an email that will be sent out shortly from EDI Co-Chairs about their upcoming meeting to review the JEDI Plan in detail. Aside from the JEDI Plan, the EDI committee has accomplished the following action items:
- Successfully completed their first book review of Caste by Isabel Wilkerson and will be ramping up for the second iteration of their book club soon.
- Developed a Grand Rounds demographics survey for the speakers.
- Held the first EDI Grand Rounds of the year on August 12, 2022, with Dr. Joely Straseski from the University of Utah, ARUP Labs: “Inclusive laboratory testing for transgender individuals: focus on utilization and reporting”
- Scheduled two other EDI Grand Rounds for the remainder of the calendar year:
- October 28, 2022: “Racial disparities in cardiovascular medicine; racial differences in cardiovascular complications due to COVID-19 from autopsy studies” - Speakers: Karol Watson, MD, PhD, UCLA DGSOM, and Rick Vander Heide, MD, PhD, Marshfield Clinic, WI
- November 18, 2022: “Removing race from eGFR equation and equity in kidney transplantation” - Speaker: Irene Kim, MD, Cedars-Sinai
Please view the overview of our Department EDI committee’s purpose, key priorities, and overview of our JEDI Plan. We look forward to advancing our EDI initiatives in the coming year. If you have any questions, concerns, or suggestions, please email the EDI Co-Chairs at [email protected].
As a department, we will continue to focus on community engagement and opportunities to advance education, research, and scientific discovery.
Sarah M. Dry, MD
Professor & Chair, Department of Pathology & Laboratory Medicine